Provided by Tiger Trade Technology Pte. Ltd.

VECTUS BIOSYSTEMS LTD

0.130
+0.0054.00%
Volume:6.11K
Turnover:782.00
Market Cap:6.94M
PE:-4.92
High:0.130
Open:0.125
Low:0.125
Close:0.125
52wk High:0.455
52wk Low:0.037
Shares:53.41M
Float Shares:22.25M
Volume Ratio:0.36
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.026
EPS(LYR):-0.033
ROE:-289.05%
ROA:-102.23%
PB:-8.61
PE(LYR):-3.90

Loading ...

Company Profile

Company Name:
VECTUS BIOSYSTEMS LTD
Exchange:
ASX
Establishment Date:
2005
Employees:
- -
Office Location:
26-34 Dunning Avenue,Unit 5, Ground Floor,Rosebery,New South Wales,Australia
Zip Code:
2018
Fax:
61 2 9697 0944
Introduction:
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. Vectus Biosystems Limited was founded in 2005 and is based in Rosebery, Australia.